We wouldn't blame Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) shareholders if they were a little worried about the fact that Brian Webster, the Founder recently netted about US$692k selling shares at an average price of US$23.21. However, that sale only accounted for 7.1% of their holding, so arguably it doesn't say much about their conviction.

Kestra Medical Technologies Insider Transactions Over The Last Year

Notably, that recent sale by Brian Webster is the biggest insider sale of Kestra Medical Technologies shares that we've seen in the last year. So it's clear an insider wanted to take some cash off the table, even below the current price of US$25.93. As a general rule we consider it to be discouraging when insiders are selling below the current price, because it suggests they were happy with a lower valuation. However, while insider selling is sometimes discouraging, it's only a weak signal. It is worth noting that this sale was only 7.1% of Brian Webster's holding.

Over the last year we saw more insider selling of Kestra Medical Technologies shares, than buying. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).

Insider Ownership Of Kestra Medical Technologies

For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Our data indicates that Kestra Medical Technologies insiders own about US$9.0m worth of shares (which is 0.6% of the company). Whilst better than nothing, we're not overly impressed by these holdings.

So What Does This Data Suggest About Kestra Medical Technologies Insiders?

Insiders haven't bought Kestra Medical Technologies stock in the last three months, but there was some selling. And our longer term analysis of insider transactions didn't bring confidence, either. Insiders own relatively few shares in the company, and when you consider the sales, we're not particularly excited about the stock. So we're not rushing to buy, to say the least. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. While conducting our analysis, we found that Kestra Medical Technologies has 1 warning sign and it would be unwise to ignore this.

But note: Kestra Medical Technologies may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.